WFNMB2022/JSNM2022/JSNMT2022

Presentation information

Print

[JSNM]Radiopharmaceuticals3: Therapy2

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [核医学]一般演題 口演

Radiopharmaceuticals3

Therapy2

Sat. Sep 10, 2022 11:00 AM - 12:00 PM Room6 (Kyoto International Conference Center 2F RoomB-2)

Chair：Izumi Umeda (Kavli Ipmu, Tokyo University), Yasuhiro Magata (Hamamatsu University School Of Medicine)

[M2VIB2] Manufacturing of [211At]NaAt for clinical trial of alpha therapy for thyroid cancer

Kazuhiro Ooe1,2、Sadahiro Naka1,3、Yoshifumi Shirakami2、Eku Shimosegawa2,4、Hiroki Kato1,2、Mitsuaki Tatsumi2,3、Yang Wang5、Hiromitsu Haba5、Atsushi Toyoshima2、Tadashi Watabe1,2 (1.Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Japan、2.Institute for Radiation Sciences, Osaka University, Toyonaka, Japan、3.Department of Radiology, Osaka University Hospital, Suita, Japan、4.Department of Molecular Imaging in Medicine, Osaka University Graduate School of Medicine、5.Nishina Center for Accelerator-Based Science, RIKEN)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

Password